Anna Protopapas
Overview
Anna Protopapas received an average of $3M in total compensation, including $508K in salary, at Mersana Therapeutics from 2016 to 2023.
2023Mersana TherapeuticsFormer President and Chief Executive Officer
2022Mersana TherapeuticsPresident and Chief Executive Officer
2021Mersana TherapeuticsPresident and Chief Executive Officer
2020Mersana TherapeuticsPresident and Chief Executive Officer
2019Mersana TherapeuticsChief Executive Officer and President
2018Mersana TherapeuticsChief Executive Officer and President
2017Mersana TherapeuticsChief Executive Officer and President
2016Mersana TherapeuticsChief Executive Officer and President
Source: SEC filings on April 26, 2024, April 28, 2023, April 29, 2022, April 27, 2021, April 20, 2020, April 23, 2019, and April 30, 2018.
Related executives
We found 11 more executives who work or worked at Mersana Therapeutics.
Martin Huber
Mersana Therapeutics
Chief Executive Officer
Arvin Yang
Mersana Therapeutics
Chief Medical Officer
Brian DeSchuytner
Mersana Therapeutics
Chief Financial Officer
Timothy Lowinger
Mersana Therapeutics
Senior Vice President, Chief Science and Technology Officer
Alejandra Carvajal
Mersana Therapeutics
Chief Legal Officer
Mohan Bala
Mersana Therapeutics
Senior Vice President, Chief Development Officer
Michael Kaufman
Mersana Therapeutics
Former Chief Manufacturing Officer
Tushar Misra
Mersana Therapeutics
Senior Vice President, Chief Manufacturing Officer
News
Mersana Therapeutics CEO Anna Protopapas' 2023 pay jumps 56% to $4.5M
April 26, 2024
Mersana Therapeutics CEO Anna Protopapas' 2022 pay falls 66% to $2.8M
April 28, 2023
Mersana Therapeutics CEO Anna Protopapas' 2021 pay jumps 226% to $8.3M
April 29, 2022
Mersana Therapeutics Chief Medical Officer Arvin Yang receives $4.5M in 2020
April 27, 2021
Mersana Therapeutics CEO Anna Protopapas' 2019 pay falls 33% to $1.7M
April 20, 2020
Mersana Therapeutics CEO Anna Protopapas' 2018 pay jumps 184% to $2.6M
April 23, 2019